Kevin Pollack
2014
In 2014, Kevin Pollack earned a total compensation of $4.7M as CFO at OPIANT PHARMACEUTICALS, a 221% increase compared to previous year.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $4,311,650 |
| Salary | $366,667 |
| Total | $4,718,317 |
Pollack received $4.3M in option awards, accounting for 91% of the total pay in 2014.
Pollack also received $40K in bonus and $366.7K in salary.
Rankings
In 2014, Kevin Pollack's compensation ranked 1,698th out of 13,032 executives tracked by ExecPay. In other words, Pollack earned more than 87.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,698 out of 13,032 | 87th |
Division Mining | 99 out of 609 | 84th |
Major group Metal Mining | 4 out of 87 | 95th |
Source: SEC filing on December 3, 2015.
Pollack's colleagues
We found two more compensation records of executives who worked with Kevin Pollack at OPIANT PHARMACEUTICALS in 2014.